Skip to main content
Joseph Calabrese, MD, Psychiatry, Cleveland, OH

JosephRCalabreseMD

Psychiatry Cleveland, OH

Director, Mood Disorders Program, UH Cleveland Medical Center. Professor, Psychiatry, CWRU School of Medicine.

Dr. Calabrese is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Calabrese's full profile

Already have an account?

  • Office

    11100 Euclid Ave
    Cleveland, OH 44106
    Phone+1 216-844-2400
    Fax+1 216-844-2875

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Psychiatry, 1984 - 1986
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Psychiatry, 1980 - 1984
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1980
  • Xavier University
    Xavier UniversityB.S., Biology, Summa Cum Laude, 1972 - 1976

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1981 - 2023
  • MD State Medical License
    MD State Medical License 1984 - 1986
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • Distinguished Life Fellow American Psychiatric Association, 2016
  • America's Top Doctors Castle Connolly, 2008-2014
  • Highly Cited as being one of the world’s most influential scientific minds within the section entitled: “Psychiatry/Psychology” Thompson Reuters, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Subthreshold PTSD and PTSD in a Prospective‐Longitudinal Cohort of Military Personnel: Potential Targets for Preventive Interventions  
    Israel Liberzon, Marijo B Tamburrino, Katherine M Keyes, Sandro Galea, Joseph R Calabrese, Depression and Anxiety
  • Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, randomized withdrawal study  
    Calabrese JR, Sanchez R, Jin D, Amatniek J, Cox K, Johnson B, Perry, Hertal P, Salzman PM, McQuate RD, Nyilas M, Carson WH, J Clin Psychiatry, 1/31/2017
  • Depression Severity and Quality of Life of Qualified and Unqualified Patients with a Mood Disorder for a Research Stuy Targeting Anhedonia in a Clinical Sample  
    Gao K, Sweet J, Su M, Calabrese J, Asian J Psychiatry, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Monotherapy and Adjunctive Latuda for treatment of bipolar depression. 
    Sau Paulo, Brazil - 1/18/2016
  • Vincent van Gogh: Biography, Family History, and Artistic Genius. 
    Cleveland Clinic - 1/1/2016
  • Recognition and Treatment of Bipolar Disorder 
    Colombia; CARICAM; Mexico; Ecuador; Chile; Brazil; Argentina - 1/29/2015
  • Join now to see all

Other

  • Six subtle signs of depression you should never ignore. 
    Calabrese JR
    1/31/2016
  • Westside Arts Festival Shines Light on Mental Illness and Addiction. 
    Calabrese JR
    1/19/2016
  • Long-Acting Injectable Aripiprazole as a Potential Maintenance Treatment for Bipolar I Disorder. 
    Calabrese JR, Otsuka and Lundbeck Data at ACNP Annual Meeting
    1/17/2016
  • Join now to see all

Press Mentions

  • FDA Approves Abilify Maintena for Bipolar I Disorder Monotherapy Treatment
    FDA Approves Abilify Maintena for Bipolar I Disorder Monotherapy TreatmentAugust 8th, 2017
  • FDA Approves First Monthly Injectable for Bipolar Disorder
    FDA Approves First Monthly Injectable for Bipolar DisorderJuly 31st, 2017
  • LAI Aripiprazole Found to Reduce Recurrence of Mood Episodes
    LAI Aripiprazole Found to Reduce Recurrence of Mood EpisodesMarch 16th, 2017
  • Join now to see all

Grant Support

  • Psychosocial Intervention To Promote Treatment Adherence In CmchNational Institute Of Mental Health2007
  • Phenomenology And Identification Of Juvenile BPD In A Community SettingNational Institute Of Mental Health2007
  • Combination Therapy In Dual Diagnosis Rapid Cycling BPD In Both The Tertiary CareNational Institute Of Mental Health2007
  • Bipolar Disorder Across The Life SpanNational Institute Of Mental Health2003–2007
  • Combination Therapy In Bipolar Rapid CyclingNational Institute Of Mental Health2002–2004
  • Valproate Versus Lithium In Bipolar Rapid CyclingNational Institute Of Mental Health1995–1999
  • Valproate And Lithium In The Prophylaxis Of The Manic Phase Of Bipolar DisorderNational Institute Of Mental Health1996